Pavlos Papavasiliou, Rodrigo Arrangoiz and Jeffrey M. Farma
Cutaneous malignancies constitute some of the most commonly diagnosed cancers in the United States (USA), comprising more than half of all cancers diagnosed per year [1]. In this review article we aim to present our experience at a tertiary referral center using PET/CT in the staging and treatment planning in patients with Merkel cell carcinoma (MCC) and melanoma and review the current literature.
分享此文章
English 
Spanish 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 